PABPC6, denoted as Poly(A) Binding Protein Cytoplasmic 6, is part of the larger family of poly(A) binding proteins renowned for their pivotal roles in various cellular functions associated with mRNA dynamics. These proteins, including PABPC6, are characterized by their pronounced affinity for the poly(A) tail segment of mRNA molecules. This interaction is not merely superficial; it imparts stability to the mRNA, ensuring its longevity and safeguarding it from untimely degradation. This stabilizing action is of paramount importance for the cellular machinery, as it ensures that the mRNA is available for efficient translation into proteins. Moreover, the binding of PABPC6 to the mRNA's poly(A) tail facilitates the mRNA's effective export from the nucleus and ensures its optimal positioning on the ribosome, the cellular apparatus responsible for protein synthesis.
PABPC6 Activators are specialized molecules that augment or bolster the inherent activity of PABPC6. By invigorating the functionality of PABPC6, such activators could significantly amplify the mRNA's stabilization, leading to more efficient and enhanced translation processes. In the context of cellular dynamics, the presence of these activators could imply a surge in protein synthesis rates, given the elevated stability and translation readiness of the mRNAs. The conceptualization, design, or discovery of PABPC6 activators would hinge on an intricate understanding of the protein's molecular structure, its nuanced interactions with mRNAs, and its role within the larger translation initiation complex. The overarching intrigue surrounding such activators revolves around their ability to increase cellular protein synthesis rates, offering a unique vantage point into the intricate dance of molecules within the cell and the possible avenues to influence it.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with DNA-dependent RNA synthesis, potentially affecting the transcription and stability of various mRNAs, including PABPC6. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to DNA and inhibits transcription, potentially impacting PABPC6 expression. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Known to inhibit nuclear export, which might influence the cytoplasmic levels of nuclear proteins and mRNAs, including PABPC6. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, it can influence gene expression patterns, possibly affecting PABPC6 expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II, potentially affecting transcription of genes, including PABPC6. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
A potent inhibitor of RNA polymerase II, which might reduce the transcription of various genes, including PABPC6. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, it can influence gene expression by modifying chromatin structure, potentially affecting PABPC6 levels. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
By inhibiting glycolysis, it can affect various cellular processes, which might influence PABPC6 expression. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $112.00 $394.00 | 8 | |
Causes DNA damage, potentially influencing the transcription and stability of several mRNAs, including PABPC6. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits DNA topoisomerase I, potentially impacting transcription and replication, thus affecting PABPC6 expression. | ||||||